The 2021 Journal of Hepatology paper “Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort” is the largest prospective study to estimate NAFLD and NASH prevalence in an asymptomatic population, with 664 patients evaluated. In this conversation, three of the paper’s co-authors discuss the reasons for conducting this study, the methodology they designed and some key results. They paint a stark picture of a disease with far greater frequency and severity than currently accepted data suggest.
TOPICS: AASLD, COVID-19, Diabetes, Diagnostic Tests, EchoSens, education, Fibrosis Level 3, MRI-PDFF, NAFLD, NASH, non-invasive liver testing, Obesity, Perspectum Diagnostics, population screening, social policy, Fibrosis Level 2, Epidemiology, San Antonia Military Medical Center,
Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast